Insulin Glargine (Lantus) 300IU Pen

Premium HealthCare UK Insulin Glargine 300IU is a long-acting basal insulin analogue studied for 24-hour glucose management and basal insulin pharmacology research.

Key Details
– 300 IU insulin pen
– Subcutaneous injection via pen device

Research Benefits
– Peakless 24-hour duration providing stable basal insulin coverage
– Studied for type 1 and type 2 diabetes basal insulin research
– Steady-state plasma concentration reduces nocturnal hypoglycaemia risk
– Insulin receptor and metabolic pathway research applications
– Comparative pharmacokinetics versus NPH insulin

Suggested Research Protocol
– Dose: Research protocol and glucose monitoring dependent
– Administer once daily at consistent time

Quality Assurance: Pharmaceutical grade, batch verified.